coronavirus

Favipiravir, also known as T-705, Avigan, or favilavir is an antiviral drug being developed by Toyama Chemical (Fujifilm group) of Japan with activity against many RNA viruses.

Favipiravir.png
In February 2020 Favipiravir was being studied in China for experimental treatment of the emergent COVID-19 (novel coronavirus) disease. On March 17 it was found to be effective in treating the infection in two trials in Wuhan and Shenzhen. Like certain other experimental antiviral drugs (T-1105 and T-1106), it is a pyrazinecarboxamide derivative.
Favipiravir is also active against influenza viruses, West Nile virus, yellow fever virus, foot-and-mouth disease virus as well as other flaviviruses, arenaviruses, bunyaviruses and alphaviruses. Activity against enteroviruses and Rift Valley fever virus has also been demonstrated. Favipiravir showed limited efficacy against Zika virus in animal studies, but was less effective than other antivirals such as MK-608. The agent has also shown some efficacy against rabies, and has been used experimentally in some humans infected with the virus.
 
Why not inject everyone under 50 with the virus and then the nation goes for a 2-week lockdown.
After 2 weeks of isolation, herd immunity is achieved and the economy can be started in full flow.
Now we are going to continue stuttering for years.
 

Russy

Village Elder
Do you have any idea about Herd immunity and covid 19
Why not inject everyone under 50 with the virus and then the nation goes for a 2-week lockdown.
After 2 weeks of isolation, herd immunity is achieved and the economy can be started in full flow.
Now we are going to continue stuttering for years.
 
Why not inject everyone under 50 with the virus and then the nation goes for a 2-week lockdown.
After 2 weeks of isolation, herd immunity is achieved and the economy can be started in full flow.
Now we are going to continue stuttering for years.
But we have seen previously infected people get infected again. Besides, would people under 50 knowingly accept to be infected?
 

Top